Showing results (871-880 of 2,457) with videos related to
Sort By:
Pageof 246
Therapie|October 28, 2011
[Neonatal risks of drugs exposure at the end of pregnancy]Elisabeth Autret-Leca, Hawaré Cissoko, Annie Pierre Jonville-BéraTherapie|August 9, 2011
[Modeling of antiretroviral response from taxonomy of CD4 cells count trajectories in profound immunodeficiency setting]Danho Pascal Abrogoua, Brou Jérôme Kablan, Gilles Aulagner, et al.Therapie|August 9, 2011
[H1N1 influenza vaccines in Tunisia: efficiency and safety]Amel Chaabane, Karim Aouam, Nadia Ben Fredj, et al.Therapie|August 20, 2011
Role of the post-marketing authorisation studies in drug risk surveillance: specifications and methodologiesFlorence Tubach, Véronique Lamarque-Garnier, Anne Castot, et al.Therapie|September 1, 1990
[Follow-up of elderly patients after emergency hospitalization for severe drug reactions]C Pinchon, J Fialip, R Dumas, et al.Therapie|September 1, 1990
[Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics]P Carlier, G Lagier, A Castot, et al.Therapie|September 1, 1990
[Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center]G Mignot, J Biaggi, P Lethurgez, et al.Therapie|September 1, 1990
[Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance]A Castot, C Benzaken, F Wagniart, et al.Therapie|September 1, 1990
[Therapeutic high-doses of digoxin with blood level determinations in 31 out of 150 elderly hospitalized patients treated over a year]C Bellamy, A Castot, P Arsac, et al.Therapie|September 1, 1990
[Recurrent psychiatric manifestations during malaria prevention with mefloquine. A case report]F Rodor, G Bianchi, S Grignon, et al.Pageof 246